[HTML][HTML] Tumour T1 changes in vivo are highly predictive of response to chemotherapy and reflect the number of viable tumour cells – a preclinical MR study in mice

C Weidensteiner, PR Allegrini, M Sticker-Jantscheff… - BMC cancer, 2014 - Springer
Background Effective chemotherapy rapidly reduces the spin–lattice relaxation of water
protons (T 1) in solid tumours and this change (ΔT 1) often precedes and strongly correlates …

Quantified tumor T1 is a generic early-response imaging biomarker for chemotherapy reflecting cell viability

PMJ McSheehy, C Weidensteiner, C Cannet… - Clinical Cancer …, 2010 - AACR
Purpose: Identification of a generic response biomarker by comparison of
chemotherapeutics with different action mechanisms on several noninvasive biomarkers in …

Multinuclear NMR and MRI reveal an early metabolic response to mTOR inhibition in sarcoma

V Di Gialleonardo, HN Aldeborgh, V Miloushev… - Cancer research, 2017 - AACR
Biomarkers predicting rapalog responses in sarcomas where PI3K and mTOR are often
hyperactivated could improve the suitable recruitment of responsive patients to clinical trials …

[HTML][HTML] Intracellular Water Lifetime as a Tumor Biomarker to Monitor Doxorubicin Treatment via FFC-Relaxometry in a Breast Cancer Model

MR Ruggiero, S Baroni, V Bitonto, R Ruiu… - Frontiers in …, 2021 - frontiersin.org
This study aims to explore whether the water exchange rate constants in tumor cells can act
as a hallmark of pathology status and a reporter of therapeutic outcomes. It has been shown …

Assessing responses to cancer therapy using molecular imaging

AA Neves, KM Brindle - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2006 - Elsevier
Tumor responses to therapy in the clinic are still evaluated primarily from non-invasive
imaging measurements of reductions in tumor size. This approach, however, lacks sensitivity …

Anti-angiogenic/vascular effects of the mTOR inhibitor everolimus are not detectable by FDG/FLT-PET

M Honer, T Ebenhan, PR Allegrini, SM Ametamey… - Translational …, 2010 - Elsevier
Noninvasive functional imaging of tumors can provide valuable early-response biomarkers,
in particular, for targeted chemotherapy. Using various experimental tumor models, we have …

mTOR senses intracellular pH through lysosome dispersion from RHEB

ZE Walton, RC Brooks, CV Dang - Bioessays, 2019 - Wiley Online Library
Acidity, generated in hypoxia or hypermetabolic states, perturbs homeostasis and is a
feature of solid tumors. That acid peripherally disperses lysosomes is a three‐decade‐old …

[HTML][HTML] FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo

D Cejka, C Kuntner, M Preusser… - British journal of …, 2009 - nature.com
This study aimed to test whether [18 F] fluoro-D-glucose (FDG) uptake of tumours measured
by positron emission tomography (PET) can be used as surrogate marker to define the …

[HTML][HTML] Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors

S Faes, AP Duval, A Planche, E Uldry, T Santoro… - Molecular cancer, 2016 - Springer
Background Blocking the mechanistic target of rapamycin complex-1 (mTORC1) with
chemical inhibitors such as rapamycin has shown limited clinical efficacy in cancer. The …

[PDF][PDF] New imaging techniques in cancer management

SJ Gwyther - Annals of oncology, 2005 - Citeseer
Cancer continues to be one of the major causes of death worldwide in the 21st century,
responsible for 6 million (12%) of the worldwide total deaths [1]. Throughout their lifetime …